Programma cfDNA Dag 2022
Presentaties 2022
- Current and future perspectives of liquid biopsies in genomics-driven oncology (Ellen Heitzer, Graz, Austria)
- Leveraging cfDNA biology and fragmentation to boost liquid biopsy (Florent Mouliere, AmsterdamUMC)
- Cancer of Unknown Primary (CUP) diagnosis using cfRRBS-methylation profiling (Jilke De Wilde, VIB-UGent, Belgium)
- ctDNA monitoring by methylated cfDNA sequencing (cfMeD-seq) of LpnPI digested fragments (Saskia Wilting, ErasmusMC)
- Dynamic changes of ctDNA predict clinical outcome in NSCLC patients treated with immune checkpoint inhibitors (Harry Groen, UMCG)
- Elucidating Prostate Cancer Behaviour During Treatment using ctDNA (Niven Mehra, RadboudMC)
- Diagnosing leptomeningeal metastases in cancer patients: should we use cells or ctDNA? (Dieta Brandsma en Mirjam Boelens, NKI)
- COIN-session
